Risankizumab efficacy and safety in psoriatic patients with latent tuberculosis infection: A multicentric real-world study
Risankizumab efficacy and safety in psoriatic patients with latent tuberculosis infection: A multicentric real‐world study
Raimondo, Annunziata;Lembo, Serena
2024-01-01
Abstract
Risankizumab efficacy and safety in psoriatic patients with latent tuberculosis infection: A multicentric real-world studyFile in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
